What is the appropriate management for a 2 cm adrenal lesion that appears benign on imaging?

Management of a 2 cm Benign-Appearing Adrenal Lesion

A 2 cm adrenal lesion that appears benign on imaging requires comprehensive hormonal evaluation but typically does not need follow-up imaging or surgery if it is truly benign (<10 HU on non-contrast CT) and hormonally inactive. 1

Initial Diagnostic Approach

Imaging Characterization

The first critical step is confirming the benign nature through proper imaging:

• Non-contrast CT is the gold standard first-line test to measure Hounsfield Units (HU) 1, 2
• Lesions with HU ≤10 are definitively benign (0% malignancy risk) and require no additional imaging regardless of size 2
• Lesions with HU 10-20 are indeterminate (0.5% malignancy risk) and warrant second-line imaging with either washout CT or chemical shift MRI 1, 2
• Lesions with HU >20 are suspicious (6.3% malignancy risk) and require comprehensive evaluation 3

Important caveat: Approximately one-third of pheochromocytomas can washout like adenomas on contrast CT, and one-third of adenomas don't washout in the typical adenoma range. Additionally, some malignant masses can mimic benign washout patterns. 1

Mandatory Hormonal Evaluation

All patients with adrenal incidentalomas require comprehensive hormonal screening regardless of imaging appearance or size. 1, 2 This is non-negotiable because imaging alone is imperfect.

Required tests for all patients:

1. 1 mg dexamethasone suppression test (preferred screening for autonomous cortisol secretion)

   • Cortisol ≤50 nmol/L (≤1.8 µg/dL) = normal
   • Cortisol >50 nmol/L (>1.8 µg/dL) = mild autonomous cortisol secretion (MACS) 2

2. Plasma or 24-hour urinary metanephrines for pheochromocytoma screening

   • Exception: Can omit if HU <10 on CT AND no signs/symptoms of catecholamine excess 1
   • Must be done before any biopsy to avoid hypertensive crisis

3. Aldosterone-to-renin ratio if patient has hypertension and/or hypokalemia

   • Ratio >30 requires confirmatory testing 3

4. Serum androgen testing only if suspected adrenocortical carcinoma or virilization signs present 1

Management Based on Results

If Benign (<10 HU) AND Non-Functional AND <4 cm

No further follow-up imaging or functional testing is required. 1 This is a strong recommendation with moderate quality evidence.

Your 2 cm lesion falls into this category if it meets all three criteria. The vast majority (71-84%) of adrenal incidentalomas are nonfunctioning adenomas. 1

If Benign (<10 HU) AND Non-Functional BUT ≥4 cm

Repeat imaging in 6-12 months due to higher malignancy risk with larger lesions. 1

If Indeterminate Imaging (HU 10-20 or unclear)

Shared decision-making is required. Options include:

• Repeat imaging in 3-6 months, OR
• Surgical resection 1

Discuss at multidisciplinary meeting with endocrinology, surgery, and radiology. 1

If Hormonally Active

Surgery is indicated for:

• Pheochromocytomas (minimally invasive approach when feasible) 1
• Aldosterone-secreting adenomas (after adrenal vein sampling confirmation) 1
• Clinically apparent Cushing's syndrome 1
• MACS in younger patients with progressive metabolic comorbidities attributable to cortisol excess (after shared decision-making) 1, 3

Recent evidence shows that surgical intervention for MACS with documented comorbidities demonstrates superior cardiovascular and metabolic outcomes compared to medical management alone. 3

Growth Surveillance Thresholds (If Follow-Up Indicated)

• Growth >5 mm/year: Consider adrenalectomy after repeating functional work-up 1
• Growth rate >0.8 cm/year: Predicts malignancy 3
• Growth <3 mm/year: No further imaging or functional testing required 1

Critical Pitfalls to Avoid

1. Never biopsy without excluding pheochromocytoma first - risk of hypertensive crisis 1
2. Don't skip hormonal evaluation based on imaging alone - lipid-poor adenomas overlap with malignant masses and pheochromocytomas 1
3. Don't assume washout CT is definitive - significant false positive and false negative rates exist 1
4. Don't forget that adrenal lesions in young adults, children, and pregnant patients are more likely malignant - expedite evaluation 1

Special Considerations

Biopsy is rarely indicated and should only be considered when diagnosing metastatic disease from extra-adrenal malignancy would change management. Never biopsy suspected adrenocortical carcinoma due to needle tract seeding risk. 1